Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Jaan, Eha"'
Autor:
Anette Caroline Kõre, Tuuli Joonsalu, Martin Serg, Priit Pauklin, Jüri Voitk, Indrek Roose, Jaan Eha, Priit Kampus
Publikováno v:
Blood Pressure, Vol 33, Iss 1 (2024)
Background Carotid-femoral pulse wave velocity (cfPWV) and central pulse pressure (PP) are recognised as significant indicators of vascular health and predictors of cardiovascular outcomes. In this study, associations between central hemodynamics and
Externí odkaz:
https://doaj.org/article/1c9dfa327d5241c693fa9b45d61f6c57
Autor:
Priit Pauklin, Toomas Marandi, Mart Kals, Tiia Ainla, Katrin Martinson, Jaan Eha, Priit Kampus
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was to study the lifeday coverage (LDC) of OAC prescriptions
Externí odkaz:
https://doaj.org/article/ddefaef17edd4913b40210c795d5999a
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Relatively high rates of adherence to myocardial infarction (MI) secondary prevention medications have been reported, but register-based, objective real-world data is scarce. We aimed to analyse adherence to guideline-recommended
Externí odkaz:
https://doaj.org/article/0f02e8e8df3f4a55a5e5d66ef0618385
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 8, Pp 1581-1587 (2021)
Abstract Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and beta blockers (BBs) are the drugs of choice for rate or rhythm control in these patients. The purpose of this study was to describe differences in arterial stiff
Externí odkaz:
https://doaj.org/article/f134cc3bb01d4f19a720f88c0f4ffc84
Autor:
Karl Kuusik, Teele Kasepalu, Mihkel Zilmer, Jaan Eha, Kaido Paapstel, Kalle Kilk, Aune Rehema, Jaak Kals
Publikováno v:
Metabolites, Vol 13, Iss 7, p 856 (2023)
Remote ischemic preconditioning (RIPC) has demonstrated protective effects in patients with lower extremity arterial disease (LEAD) undergoing digital subtraction angiography (DSA) and/or percutaneous transluminal angioplasty (PTA). This study aimed
Externí odkaz:
https://doaj.org/article/24ce404199ca4043b4bbe451b67c97a0
Autor:
Teele Kasepalu, Karl Kuusik, Urmas Lepner, Joel Starkopf, Mihkel Zilmer, Jaan Eha, Mare Vähi, Jaak Kals
Publikováno v:
Nutrition & Metabolism, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background Vascular surgery patients have reduced tissues` blood supply, which may lead to mitochondrial dysfunction and accumulation of acylcarnitines (ACs). It has been suggested that remote ischaemic preconditioning (RIPC) has its organ p
Externí odkaz:
https://doaj.org/article/b15c5103fb4c459eb8d92cab67a78319
Autor:
Kadri Eerik, Teele Kasepalu, Karl Kuusik, Jaan Eha, Mare Vähi, Kalle Kilk, Mihkel Zilmer, Jaak Kals
Publikováno v:
Biomolecules, Vol 12, Iss 9, p 1312 (2022)
Background: remote ischemic preconditioning (RIPC) is a phenomenon in which short episodes of ischemia are applied to distant organs to prepare target organs for more prolonged ischemia and to induce protection against ischemia-reperfusion injury. Th
Externí odkaz:
https://doaj.org/article/1764974f08dd47e8bf9b963cee65a414
Autor:
Teele Kepler, Karl Kuusik, Urmas Lepner, Joel Starkopf, Mihkel Zilmer, Jaan Eha, Kaido Paapstel, Jaak Kals
Publikováno v:
Artery Research, Vol 25, Iss 1 (2020)
Objectives: The primary aim of this study was to evaluate the effects of remote ischaemic preconditioning (RIPC) on preventing the leakage of cardiac damage biomarkers in patients undergoing vascular surgery. Methods: Randomised, sham-controlled, do
Externí odkaz:
https://doaj.org/article/8f7b38d08cf143fc90681764bc9c8610
Publikováno v:
Artery Research, Vol 25, Iss 1 (2020)
Objectives: Remote ischaemic preconditioning (RIPC) is a phenomenon that promotes protection of tissues and organs against ischaemia-reperfusion injury. RIPC has been shown to reduce myocardial and renal injury but its effect on arterial stiffness in
Externí odkaz:
https://doaj.org/article/71f9038979754d1b9b9b4a2c40f78ca2
Autor:
Tuuli Teeäär, Martin Serg, Kaido Paapstel, Mare Vähi, Jaak Kals, John R. Cockcroft, Mihkel Zilmer, Jaan Eha, Priit Kampus
Publikováno v:
International Journal of Hypertension, Vol 2020 (2020)
Objective. Whether the inferior ability of atenolol to reduce central (aortic) compared to peripheral (brachial) blood pressure (BP) is related to its heart rate (HR)-dependent or -independent effects, or their combination, remains unclear. To provid
Externí odkaz:
https://doaj.org/article/6fd6b6b7b9994a5d93ec7edad4df1d5f